| New study provides ‘substantial evidence’ paclitaxel-coated devices are safe when treating lower-limb PAD |
| Cardiologists see value in AI-based plaque assessments |
| Donor hearts more likely to be accepted when the transplant candidate is female or white |
| Cardiologists received $1.3B in industry payments over 10-year period, No. 3 among all healthcare specialties |
| FDA approves Medtronic’s next-generation TAVR system with new frame design |
| Heart attacks after TAVR: New AMI data ‘reassuring’ at first glance, but questions remain |
| Microplastics in carotid plaques increase risk of adverse cardiovascular outcomes |
| New data registry will track how AI-powered plaque assessments impact cardiologist decisions |
| FDA approves new drugs for pulmonary arterial hypertension from Johnson & Johnson, Merck |
| Report: Johnson & Johnson once again considering deal to acquire Shockwave Medical |
| Hospital accused of implanting experimental heart valve in young patient without proper consent |
| TAVR is often more cost-effective than SAVR—but not always |
| Radiology AI company gains FDA clearance for new CT offerings focused on PE, stroke |
| SPECT still has an important role to play in nuclear cardiology |
| VR before TAVR predicts paravalvular leak in high-risk patients |
| Biosense Webster takes key step toward FDA approval for Varipulse PFA system |
| Novo Nordisk to acquire biotech company working on new heart failure drug for $1.1B |
| ACC.24 to make the business side of cardiology a priority |
| Medicare will now cover weight loss drug semaglutide if taken for heart benefits |
| Going green in the cath lab makes economic sense |
| FDA grants new implant for BTK arterial disease its breakthrough device designation |
| A possible remedy for cardiology’s staffing shortages: heart failure internists |
| FDA announces new recall impacting more than 66,000 Impella heart pumps after 49 deaths |
| ‘Highly effective’: COVID-19 vaccines reduced risk of heart failure, other cardiovascular complications after infection |
| FDA approves new hypertension drug months after Idorsia reacquired rights for $343M |
| New DCD heart transplant technique could reduce risk of serious injury |
| Interventional techniques can help limit amputations among CLI patients |
| Cardiologists are first in world to remove unstable Watchman devices with FDA-cleared retrieval system |
| Intermittent fasting may increase risk of death from heart attack, stroke |
| Doctors form new coalition focused on reducing private equity’s role in cardiology, other healthcare specialties |
| Incidental breast calcifications on mammograms linked to much higher risk of cardiovascular disease |
| FDA grants new resorbable scaffold for CLTI its breakthrough device designation |
| Diabetes increases risk of death, complications when patients undergo CABG or PCI for left main disease |
| Edwards, Abbott share updated TAVR data at CRT 2024 |
| Cardiologist shares his long journey from Libya to United States |
| Too much niacin? Excess vitamin B3 may increase risk of heart attack, stroke |
| Peripheral artery disease is out of control in many rural, low income communities |
| New research underway on credit card-sized heart monitor that synthesizes 12-lead ECGs |
| Cardiologists share historic research that led to FDA’s long-awaited approval of coronary DCB |
| Most physicians think private equity is bad for healthcare |
| Cognitive impairment among heart failure patients: How cardiologists can help |
| Cardiologist urges cath labs to adopt radiation shields: ‘It is time to protect ourselves’ |
| Heart issues more common in adults who drink soda, other sweetened beverages |
| AI-based CAD assessments as accurate as FFR, new 10-year study confirms |
| TAVR vs. SAVR: Medtronic’s Evolut platform linked to cost savings, key benefits for low-risk patients |
| Heart health experts explore CT’s role in the diagnosis of CAD in women |
| Abbott recalls device for tracking LVAD data after 8 injuries |
| ACC, SCAI say new funding bill did not do enough to limit Medicare reimbursement cuts to cardiology services |
| Vascular ‘paint’ for heart patients earns researchers $2.8M in funding |
| A big win for Wegovy: Weight loss drug semaglutide first in history to gain FDA approval for reducing heart risks |
| Most cardiologists would take a lower salary for a better work-life balance |
| Swiss startup targets stroke patients with first US install of robotics system for remote vascular interventions |
| Some older patients taking aspirin to prevent CVD may be doing more harm than good |
| AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do |
| FDA announces new Class I recall of drainage systems after 26 injuries |
| Coronary calcium scoring predicts when chest pain patients can skip invasive testing |
| FDA clears first over-the-counter wearable device for continuous glucose monitoring |
| TMVR vs. mitral valve surgery: Tendyne linked to improved survival in elderly patients |
| FDA grants AI software for imaging-based heart assessments its breakthrough device designation |
| Permanent pacemaker implantation after TAVR increases healthcare costs by $24,000 per patient |
| Private equity-backed cardiology management group expands its leadership team |
| How a big CMS update on carotid stenting could impact interventional cardiology |
| Ultra-processed foods linked to 32 adverse health outcomes, including CVD-related death and diabetes |
| Family man from Netherlands named world’s longest-surviving heart transplant recipient |
| ‘Just like smoking tobacco’: Cannabis use increases stroke risk by 42%, heart attack risk by 25% |
| Healthcare fraud: DOJ recovered $1.9B in 2023, including several key settlements related to cardiology |
| FDA approves Boston Scientific’s new drug-coated balloon for coronary in-stent restenosis |
| The many benefits of using low-cost CT coronary calcium scoring to screen patients |
